Literature DB >> 9430835

Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application.

M K Kuhlmann, G Burkhardt, H Köhler.   

Abstract

Cisplatin preferentially accumulates in cells of the S3 segment of the renal proximal tubule and is toxified intracellularly by hydration. The earliest manifestation of toxicity is inhibition of protein synthesis. GSH depletion is another important mechanism causing CP toxicity. Intracellular binding to SH groups leads to GSH depletion, resulting in lipid peroxidation and eventually mitochondrial damage. New measures to prevent GSH depletion and scavenge intracellular free oxygen radicals have been tried in clinical studies. Promising results indicate that cisplatin nephrotoxicity can be further reduced in the future.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430835     DOI: 10.1093/ndt/12.12.2478

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  61 in total

1.  Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT.

Authors:  A Kitamura; S Kobayashi; T Matsushita; H Fujinawa; K Murase
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

2.  Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats.

Authors:  Abdelazim Ibrahim; Mabrouk A Abd Eldaim; Mohamed M Abdel-Daim
Journal:  Cytotechnology       Date:  2015-02-27       Impact factor: 2.058

3.  Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).

Authors:  Qing Li; Dong Guo; Zhongqi Dong; Wei Zhang; Lei Zhang; Shiew-Mei Huang; James E Polli; Yan Shu
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-31       Impact factor: 4.219

4.  Oral Nigella sativa oil and thymoquinone administration ameliorates the effect of long-term cisplatin treatment on the enzymes of carbohydrate metabolism, brush border membrane, and antioxidant defense in rat intestine.

Authors:  Faaiza Shahid; Zeba Farooqui; Aijaz Ahmed Khan; Farah Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-04       Impact factor: 3.000

5.  Protective effect of Pueraria tuberosa DC. embedded biscuit on cisplatin-induced nephrotoxicity in mice.

Authors:  Yamini B Tripathi; Santosh Nagwani; Pooja Mishra; Alok Jha; Shashi Pandey Rai
Journal:  J Nat Med       Date:  2011-06-30       Impact factor: 2.343

6.  Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.

Authors:  Xiaojing Xu; Lifang Han; Li Duan; Yingchun Zhao; Huaping Yang; Boting Zhou; Rui Ma; Ruixia Yuan; Honghao Zhou; Zhaoqian Liu
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

7.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.

Authors:  Mohamed M Abdel-Daim; Yasser S El-Sayed; Mabrouk Abd Eldaim; Abdelazim Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

8.  Protective effects of icariin on cisplatin-induced acute renal injury in mice.

Authors:  Pei Ma; Sen Zhang; Xinlin Su; Guixing Qiu; Zhihong Wu
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

9.  Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Authors:  Mohamed M Sayed-Ahmed
Journal:  Saudi Pharm J       Date:  2010-08-05       Impact factor: 4.330

Review 10.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.